Connect Sign In
LabMind podcasts
In her lab at the University of Utah, Allison Carey, MD, PhD, is using a molecular barcoding approach she developed to identify the genes that allow some strains of Mycobacterium avium to establish chronic infections and resist treatment with antibiotics. |
September 16, 2022 |
ARUP Medical Director’s Research Into a Chronic Bacterial Infection Earns a Prestigious NIAID Grant The National Institute of Allergy and Infectious Diseases has awarded Medical Director Allison Carey, MD, PhD, $1.5 million over five years to fund her groundbreaking research. |
NanoSpot.ai’s agreement with the Greek company Opto enables the commercialization and distribution in Europe of NanoSpot.ai’s line of antibody tests, including the SARS-CoV-2 test pictured here. |
September 14, 2022 |
NanoSpot.ai Announces Partnership With Opto to Commercialize SARS-CoV-2 Antibody Test in Europe NanoSpot.ai’s European commercialization agreement is the first for an antibody test originally developed through an ARUP/University of Utah/Techcyte partnership. |
ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in August. |
September 7, 2022 | ARUP Consult has released several new and updated resources for clinicians, including testing topics on kidney evaluation, gestational trophoblastic disease, and poliovirus. |
|
September 6, 2022 |
New ARUP Consult Resources Provide Information on Laboratory Testing for Poliovirus The CDC recently confirmed the first U.S. case of polio since 2013, which has raised concerns about the virus. New ARUP Consult resources inform clinicians about lab testing for poliovirus. |
These images depict the distinct genetic profiles found in patients with pathogenic germline DDX41 variants and variants of unknown significance (VUSs). |
August 31, 2022 |
New Research From ARUP and Others Provides Diagnostic Guidance on DDX41-Associated Myeloid Neoplasms New research published in Blood sheds light on diagnosis, disease characteristics, and prognoses for inherited hematologic malignancies associated with DDX41 germline variants. |
Patricia Slev, PhD, section chief of Immunology at ARUP Laboratories, coauthored a newly published study that looked at COVID-19-related risks facing emergency department workers early in the pandemic. |
August 30, 2022 | A new study for which ARUP provided COVID-19 testing and expertise found that emergency department workers early in the pandemic faced the highest risk of infection from community spread. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat